Kesso-Bamate en es it fr

Kesso-Bamate Brand names, Kesso-Bamate Analogs

Kesso-Bamate Brand Names Mixture

  • No information avaliable

Kesso-Bamate Chemical_Formula


Kesso-Bamate RX_link

No information avaliable

Kesso-Bamate fda sheet

Kesso-Bamate msds (material safety sheet)

Kesso-Bamate Synthesis Reference

No information avaliable

Kesso-Bamate Molecular Weight

309.469 g/mol

Kesso-Bamate Melting Point

< 25 oC

Kesso-Bamate H2O Solubility

Soluble as HCl salt

Kesso-Bamate State


Kesso-Bamate LogP


Kesso-Bamate Dosage Forms

Tablets (oral, 1 mg)

Kesso-Bamate Indication

Used for the symptomatic treatment of parkinsonism.

Kesso-Bamate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Kesso-Bamate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Kesso-Bamate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Kesso-Bamate Patient Information

Kesso-Bamate Organisms Affected

Humans and other mammals